Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (35 quarters reported)
$136M in Q4 2017 → $580M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| LB Lakefront Biotherapeutics Nv | 10.6% | Added 32% | 2,043,344 | $61.3M |
| Janux Therapeutics Inc | 10.1% | Added 7.2% | 3,804,481 | $58.4M |
| Nektar Therapeutics | 9.7% | Added 10% | 810,000 | $56.5M |
| Boston Scientific Corp | 9.3% | Added 60% | 1,270,273 | $54.2M |
| Shattuck Labs Inc | 7.1% | Added 19% | 5,957,877 | $41.3M |
| Insmed Inc | 6.9% | New | 375,609 | $40M |
| Alnylam Pharmaceuticals Inc | 5.1% | Added 29% | 98,080 | $29.5M |
| Syndax Pharmaceuticals Inc | 4.5% | Added 56% | 1,200,000 | $26.2M |
| Kura Oncology Inc | 3.8% | Trimmed 40% | 2,021,964 | $22.2M |
| Alkermes PLC | 3.6% | Trimmed 23% | 394,389 | $20.7M |
| Irhythm Holdings Inc | 3.4% | Added 1555% | 165,500 | $19.7M |
| VS Veeva Sys Inc | 3.2% | Added 23% | 106,200 | $18.8M |
| Zymeworks Inc | 3.0% | Added 25% | 674,434 | $17.6M |
| Abivax Sa | 2.5% | Added 2.3% | 107,394 | $14.3M |
| CP Crinetics Pharmaceuticals In | 2.4% | Added 7.0% | 374,666 | $14M |
| Mineralys Therapeutics Inc | 2.1% | New | 449,795 | $12.1M |
| AT Adc Therapeutics Sa | 1.4% | Trimmed 5.7% | 7,824,749 | $8.37M |
| IM Icu Med Inc | 1.3% | Added 86% | 51,000 | $7.48M |
| Intuitive Surgical Inc | 1.2% | Added 325% | 17,000 | $6.76M |
| CP Corbus Pharmaceuticals Hldgs | 1.1% | Trimmed 6.8% | 650,000 | $6.1M |
| Procept Biorobotics Corp | 1.0% | Trimmed 86% | 268,269 | $6.06M |
| Genedx Holdings Corp | 1.0% | Trimmed 84% | 85,500 | $5.87M |
| Option Care Health Inc | 1.0% | New | 270,716 | $5.68M |
| Onkure Therapeutics Inc | 0.8% | Trimmed 55% | 978,992 | $4.46M |
| Emergent Biosolutions Inc | 0.7% | Trimmed 28% | 459,952 | $3.85M |
| Pfizer Inc | 0.6% | New | 135,366 | $3.26M |
| Orthopediatrics Corp | 0.5% | Trimmed 48% | 157,500 | $3.01M |
| Rocket Pharmaceuticals Inc | 0.4% | Added 2.4% | 700,000 | $2.39M |
| An2 Therapeutics Inc | 0.4% | Trimmed 8.0% | 474,638 | $2.3M |
| Pliant Therapeutics Inc | 0.3% | Trimmed 18% | 1,370,233 | $1.56M |
| Tectonic Therapeutic Inc | 0.2% | Trimmed 50% | 39,731 | $1.37M |
| MH Meiragtx Hldgs PLC | 0.2% | Trimmed 97% | 90,000 | $1.22M |
| Everforth Inc | 0.2% | New | 67,500 | $1.21M |
| Rein Therapeutics Inc | 0.2% | Added 167% | 1,100,000 | $1.14M |
| Coya Therapeutics Inc | 0.2% | Trimmed 60% | 170,000 | $995K |
| Immuneering Corp | 0.0% | Trimmed 70% | 36,861 | $184K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Insmed Inc | New | +375,609 | +$40M | 6.9% |
| Procept Biorobotics Corp | Trimmed | −1,676,731 | −$37.9M | 1.0% |
| MH Meiragtx Hldgs PLC | Trimmed | −2,539,971 | −$34.3M | 0.2% |
| Genedx Holdings Corp | Trimmed | −437,963 | −$30.1M | 1.0% |
| Boston Scientific Corp | Added | +474,726 | +$20.3M | 9.3% |
| Irhythm Holdings Inc | Added | +155,500 | +$18.5M | 3.4% |
| LB Lakefront Biotherapeutics Nv | Added | +493,344 | +$14.8M | 10.6% |
| Kura Oncology Inc | Trimmed | −1,334,736 | −$14.6M | 3.8% |
| Mineralys Therapeutics Inc | New | +449,795 | +$12.1M | 2.1% |
| CG Concentra Group Holdings Par | Exited | −505,822 | −$10.8M | — |
Showing the 10 largest of 51 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Boston Scientific Corp | Added | +585,547 | +$36.7M | 8.2% |
| Genedx Holdings Corp | Added | +468,463 | +$30.1M | 5.5% |
| Icon PLC | Exited | −110,000 | −$20M | — |
| Alnylam Pharmaceuticals Inc | Added | +58,891 | +$19.5M | 4.1% |
| Alkermes PLC | New | +513,632 | +$18.2M | 3.0% |
| Shattuck Labs Inc | Added | +2,622,937 | +$16.9M | 5.3% |
| Amicus Therapeutics Inc | Exited | −1,150,000 | −$16.4M | — |
| Janux Therapeutics Inc | Added | +1,157,477 | +$16.1M | 8.1% |
| SM Select Med Hldgs Corp | Exited | −1,035,086 | −$15.4M | — |
| Galapagos Nv | Added | +475,888 | +$14.3M | 7.6% |
Showing the 10 largest of 53 changes.
quarter ended December 31, 2025 · filed February 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Procept Biorobotics Corp | Added | +1,303,009 | +$41M | 9.0% |
| Nektar Therapeutics | New | +554,633 | +$23.4M | 4.8% |
| Intuitive Surgical Inc | Exited | −48,711 | −$21.8M | — |
| Janux Therapeutics Inc | Added | +1,527,173 | +$21.1M | 6.8% |
| VS Veeva Sys Inc | New | +90,133 | +$20.1M | 4.2% |
| Bridgebio Pharma Inc | Trimmed | −234,500 | −$17.9M | 0.5% |
| Phreesia Inc | New | +977,152 | +$16.5M | 3.4% |
| Roivant Sciences Ltd | Trimmed | −708,338 | −$15.4M | 2.8% |
| Dexcom Inc | Exited | −195,217 | −$13.1M | — |
| Boston Scientific Corp | Added | +133,900 | +$12.8M | 4.1% |
Showing the 10 largest of 53 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Unitedhealth Group Inc | Exited | −110,000 | −$34.3M | — |
| Intuitive Surgical Inc | New | +48,711 | +$21.8M | 5.1% |
| Galapagos Nv | Trimmed | −623,649 | −$21.6M | 9.3% |
| Amicus Therapeutics Inc | Trimmed | −1,770,511 | −$14M | 3.1% |
| Argenx Se | Trimmed | −18,700 | −$13.8M | 0.6% |
| Corcept Therapeutics Inc | New | +147,800 | +$12.3M | 2.9% |
| AT Adc Therapeutics Sa | Trimmed | −2,995,468 | −$12M | 7.0% |
| Bridgebio Pharma Inc | Trimmed | −208,187 | −$10.8M | 3.2% |
| Mirum Pharmaceuticals Inc | Exited | −200,000 | −$10.2M | — |
| Zymeworks Inc | Trimmed | −560,293 | −$9.57M | 3.0% |
Showing the 10 largest of 50 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Unitedhealth Group Inc | New | +110,000 | +$34.3M | 8.4% |
| Galapagos Nv | Added | +458,751 | +$12.8M | 12.1% |
| Amicus Therapeutics Inc | Added | +2,100,661 | +$12M | 4.9% |
| CP Crinetics Pharmaceuticals In | New | +298,123 | +$8.57M | 2.1% |
| Schrodinger Inc | Exited | −385,000 | −$7.6M | — |
| Mirum Pharmaceuticals Inc | Trimmed | −143,326 | −$7.29M | 2.5% |
| Intuitive Surgical Inc | Exited | −14,000 | −$6.93M | — |
| CG Concentra Group Holdings Par | New | +312,105 | +$6.42M | 1.6% |
| Kura Oncology Inc | Added | +1,102,869 | +$6.36M | 4.5% |
| Abcellera Biologics Inc | Exited | −2,815,652 | −$6.28M | — |
Showing the 10 largest of 46 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Bridgebio Pharma Inc | Trimmed | −385,000 | −$13.3M | 6.9% |
| AH Acadia Healthcare Company In | Trimmed | −402,000 | −$12.2M | 2.9% |
| Abcellera Biologics Inc | Trimmed | −4,534,348 | −$10.1M | 2.1% |
| Janux Therapeutics Inc | Added | +360,133 | +$9.72M | 6.1% |
| Zimmer Biomet Holdings Inc | Exited | −80,000 | −$8.45M | — |
| Argenx Se | New | +13,700 | +$8.11M | 2.7% |
| Galapagos Nv | Added | +289,898 | +$7.28M | 10.9% |
| Tectonic Therapeutic Inc | New | +398,885 | +$7.06M | 2.3% |
| Intuitive Surgical Inc | New | +14,000 | +$6.93M | 2.3% |
| Schrodinger Inc | Trimmed | −335,500 | −$6.62M | 2.5% |
Showing the 10 largest of 40 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AH Acadia Healthcare Company In | Added | +686,334 | +$27.2M | 7.6% |
| Icon PLC | New | +85,000 | +$17.8M | 4.9% |
| Mckesson Corp | Exited | −35,822 | −$17.7M | — |
| Rocket Pharmaceuticals Inc | Added | +929,337 | +$11.7M | 3.8% |
| Accolade Inc | Exited | −2,801,598 | −$10.8M | — |
| Dexcom Inc | Exited | −160,000 | −$10.7M | — |
| Cytokinetics Inc | Exited | −192,700 | −$10.2M | — |
| Zimmer Biomet Holdings Inc | Trimmed | −85,602 | −$9.04M | 2.3% |
| Amicus Therapeutics Inc | New | +920,000 | +$8.67M | 2.4% |
| Neurocrine Biosciences Inc | Exited | −62,000 | −$7.14M | — |
Showing the 10 largest of 53 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Mckesson Corp | New | +35,822 | +$17.7M | 4.4% |
| Abcellera Biologics Inc | Added | +6,726,906 | +$17.5M | 5.8% |
| KS Kelly Svcs Inc | Exited | −492,340 | −$10.5M | — |
| Janux Therapeutics Inc | New | +205,000 | +$9.31M | 2.3% |
| Galapagos Nv | Trimmed | −321,137 | −$9.25M | 7.3% |
| Dexcom Inc | Added | +110,683 | +$7.42M | 2.6% |
| Bridgebio Pharma Inc | Added | +286,810 | +$7.3M | 6.8% |
| Alkermes PLC | Exited | −275,000 | −$6.63M | — |
| IT Ishares Tr | New | +29,000 | +$6.41M | 1.6% |
| Schrodinger Inc | Added | +330,739 | +$6.14M | 3.2% |
Showing the 10 largest of 62 changes.
Loading...
